US2.ai

US2.ai is a Singapore-based company that has developed an AI-powered software platform to automate the analysis and interpretation of echocardiograms, a common medical imaging technique for assessing heart function. The company's technology aims to address the manual and time-consuming nature of traditional echocardiogram analysis, which can be prone to variability and require specialized expertise.

The platform can be integrated with various ultrasound devices, including those from major manufacturers like GE and mobile units. It automatically processes the images, performs measurements, and generates reports, effectively providing a "zero-click" solution. This automation is intended to improve the efficiency, accuracy, and consistency of cardiovascular diagnostics.

US2.ai targets healthcare providers, including hospitals and clinics, as its primary customers. The business model likely involves licensing its software to these institutions. By enabling faster and more accessible cardiac assessments, the company seeks to expand healthcare access and improve patient outcomes, particularly in settings with limited access to cardiologists.

The company has secured backing from notable investors, including IHH Healthcare, Heal Partners, Sequoia India, and EDBI, indicating confidence in its technology and market potential. US2.ai has also established partnerships with medical institutions and companies like Fujifilm, further validating its role in the evolving field of AI-driven medical diagnostics.

Keywords: echocardiography, artificial intelligence, medical imaging, cardiovascular diagnostics, healthcare software, medical reports, ultrasound, cardiology, health tech, decision support